MedTrace Logo

6-year Antibody Check After Third Vaccination Against Japanese Encephalitis

NCT02039440 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2015-02-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether there are persisting antibodies against Japanese Encephalitis 6 years after the last vaccination with IXIARO(R) and to adapt or confirm mathematical models accordingly.

Conditions

  • Post Other Specified Vaccination Encephalitis

Interventions

OTHER

Blood draw

One-time blood draw

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Herwig Kollaritsch, Prof. Dr. · Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin 1090 Wien, Kinderspitalgasse 15

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02039440 on ClinicalTrials.gov